- Home
- CLLS vs DDD Comparison
CLLS vs DDD Comparison
Compare CLLS & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- DDD
- Stock Information
- Founded
- CLLS 1999
- DDD 1986
- Country
- CLLS France
- DDD United States
- Employees
- CLLS N/A
- DDD N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- DDD Computer peripheral equipment
- Sector
- CLLS Health Care
- DDD Technology
- Exchange
- CLLS Nasdaq
- DDD Nasdaq
- Market Cap
- CLLS 299.0M
- DDD 328.3M
- IPO Year
- CLLS 2007
- DDD N/A
- Fundamental
- Price
- CLLS $2.96
- DDD $2.24
- Analyst Decision
- CLLS Buy
- DDD Hold
- Analyst Count
- CLLS 1
- DDD 3
- Target Price
- CLLS $4.00
- DDD $3.50
- AVG Volume (30 Days)
- CLLS 73.6K
- DDD 4.1M
- Earning Date
- CLLS 11-03-2025
- DDD 08-11-2025
- Dividend Yield
- CLLS N/A
- DDD N/A
- EPS Growth
- CLLS N/A
- DDD N/A
- EPS
- CLLS N/A
- DDD N/A
- Revenue
- CLLS $63,438,000.00
- DDD $413,342,000.00
- Revenue This Year
- CLLS N/A
- DDD N/A
- Revenue Next Year
- CLLS $66.76
- DDD $2.43
- P/E Ratio
- CLLS N/A
- DDD N/A
- Revenue Growth
- CLLS 223.09
- DDD N/A
- 52 Week Low
- CLLS $1.10
- DDD $1.32
- 52 Week High
- CLLS $3.35
- DDD $5.00
- Technical
- Relative Strength Index (RSI)
- CLLS 63.19
- DDD 56.59
- Support Level
- CLLS $2.53
- DDD $2.08
- Resistance Level
- CLLS $3.35
- DDD $2.36
- Average True Range (ATR)
- CLLS 0.16
- DDD 0.17
- MACD
- CLLS 0.02
- DDD -0.01
- Stochastic Oscillator
- CLLS 58.82
- DDD 34.51
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.